AMGN compared with IOVA: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

IOVAIovance Biotherapeutics, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

IOVAIovance Biotherapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

461.49▼−3.55%· post 461.15· delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

IOVAIovance Biotherapeutics, Inc.

7.71▼−11.38%· post 7.60· delayed

After hoursNov 5 '26delayed

Mkt cap$3.6BRevenue$121MQ3 FY26Revenue$264MFY25

Compare

After hoursNov 5 '26delayed

AMGNAmgen Inc

IOVAIovance Biotherapeutics, Inc.

461.49▼−3.55%post 461.15delayed

Price

7.71▼−11.38%post 7.60delayed

$258.8B

Mkt cap

$3.6B

Q3 FY26$10.4B

Revenue

$121MQ3 FY26

FY25$36.8B

Revenue

$264MFY25

AMGN461.49▼−3.55%vsIOVA7.71▼−11.38%After hoursNov 5 '26delayed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only IOVA 12

NVSNovartis Pharmasupplier

—Boehringer Ingelheim Biopharmaceuticals GmbHunlistedsupplier

—National Cancer Institute (NCI)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

National Institutes of Health (NIH)

unlistedsupplier

8 more · IOVA chain ›